Endogenic PharmacologyThe Canonical Reference
The Canonical Reference

The Next Chapter of Modern Pharmacology

For the past century, pharmacology mastered intervention from without. Endogenic pharmacology masters regulation from within. This is the canonical reference for the discipline.

Endogenic pharmacology is a discipline within modern pharmacology dedicated to modulating gene expression and cellular function from within the body's own regulatory architecture, rather than overriding the body's systems through external intervention. It complements the established discipline of exogenic pharmacology and extends the pharmacological sciences into a new mechanism of therapeutic action.

The foundational reference for endogenic pharmacology
Featured · Foundational Reference

Four decades of endogenous regulation, anchored.

The Khavinson lineage of short peptide bioregulators — characterized across institutional laboratories in Russia, Ukraine, Italy, South Korea, and the United Kingdom — forms the empirical foundation on which endogenic pharmacology rests.

Read the research

Three Pillars

The discipline, the practice, and the compounds.

The Science

Endogenic Pharmacology

The discipline. It studies how short peptide bioregulators and related compounds modulate gene expression and cellular function through the body's own regulatory architecture, drawing on four decades of peer-reviewed research from institutional laboratories across Russia, Ukraine, Italy, South Korea, and the United Kingdom.

Learn more →
The Practice

Bioregulatory Medicine

The clinical practice of endogenic pharmacology. It translates the scientific principles of endogenous regulation into therapeutic protocols across neurological, immune, vascular, longevity, and metabolic indications. Dispensed at two tiers: opticeuticals for consumer use and endoceuticals for prescription clinical care.

Learn more →
The Compounds

Bioregulators

The therapeutic class of endogenic pharmacology. Includes short peptide compositions of the Khavinson lineage and proprietary trade-named bioregulator portfolio u2014 Telogenixu2122, Thymogenixu2122, Vasogenixu2122, Dermogenixu2122, Cortigenixu2122, Lymphogenixu2122, and Gonadogenixu2122 u2014 compounds), formulated for non-injectable delivery across topical, transdermal, intranasal, sublingual, and oral routes.

Learn more →

Endogenic pharmacology is the natural extension of the pharmaceutical sciences into the next century of medicine. Where the first century mastered exogenous intervention, the next will master endogenous regulation. We are honored to found this discipline and to provide the canonical framework for its growth.
Daniel William Dorsey and Daniel Nowak
Founders, Atumnus LLC